Aveanna Healthcare shares dropped 11.9% to $9.01 in pre-market trading. The decline is attributed to the announcement of a secondary stock offering. Increased stock offerings can dilute existing shareholders' value and market confidence. Other stocks in healthcare also experienced declines, signaling market uncertainty. Secondary offerings often lead to short-term price declines due to oversupply.
AVAH reported adjusted EPS of five cents, reversing a loss from last year. Fourth-quarter sales were $519.9 million, beating expectations of $499.6 million. Revenue growth driven primarily by Private Duty Services and Medical Solutions segments. 2025 revenue guidance of $2.10-$2.12 billion aligns with analyst forecasts. Stock surged 39.57% to $5.23, signaling market confidence in the company.
